Inactive Instrument

Annidis Corporation

RHA.H

CA03589A1003

Advanced Medical Equipment & Technology

Annidis Corporation Announces the Resignation of Michael Mueller as Board of Director

September 07, 2016 at 05:53 pm EDT

Annidis Corporation announced the resignation of Michael Mueller as board of director, effective from September 1, 2016.

Latest news about Annidis Corporation

Annidis Corporation Announces Executive Resignations	18-02-26	CI
Annidis Corporation Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2017	17-11-23	CI
Annidis Corporation Announces Unaudited Consolidated Financial Results for the Second Quarter and Six Months Ended June 30, 2017	17-08-25	CI
Annidis Corporation Announces Audited Consolidated Earnings Results for the First Quarter Ended March 31, 2017	17-05-25	CI
Annidis Corporation Announces Audited Consolidated Earnings Results for the Twelve Months Ended December 31, 2016	17-04-28	CI
Annidis Corporation Announces Executive Changes	17-02-24	CI
Annidis Corporation announced that it expects to receive CAD 2.18 million in funding	16-11-29	CI
Annidis Corporation Announces Private Placement of $500,000 Promissory Note	16-09-21	CI
Annidis Corporation Reports Unaudited Consolidated Earnings Results for the Second Quarter Ended June 30, 2016	16-09-07	CI
Annidis Corporation Announces the Resignation of Michael Mueller as Board of Director	16-09-07	CI
Annidis Corporation announced that it has received CAD 0.5 million in funding from Mistarunited Technology Co., Limited	16-08-31	CI
Annidis Corporation Announces Private Placement of $221,000 Promissory Note	16-08-08	CI
Annidis Corporation announced that it has received CAD 0.22 million in funding from Mistarunited Technology Co., Limited	16-07-28	CI
Annidis Corporation Auditor Raises 'Going Concern' Doubt	16-04-28	CI
Annidis Corporation Announces Management Changes	16-04-18	CI
Annidis Corporation announced that it has received CAD 1.3 million in funding from YIMAI Technology International Company Limited	16-04-17	CI
Annidis Corporation announced that it has received CAD 0.1 million in funding from YIMAI Technology International Company Limited	16-04-13	CI
Annidis Corporation announced that it expects to receive CAD 0.1 million in funding from YIMAI Technology International Company Limited	16-03-30	CI
Annidis Corporation announced that it has received CAD 0.15 million in funding from YIMAI Technology International Company Limited	16-03-16	CI
Annidis Corporation announced that it has received CAD 0.87 million in funding from YIMAI Technology International Company Limited	16-03-03	CI
Annidis Corporation Announces Private Placement of $150,000 Promissory Note	16-02-22	CI
Annidis Corporation Announces Management Changes	16-01-05	CI
Annidis Corporation Announces Earnings Results for the Nine Months Ended September 30, 2015	15-12-20	CI
Annidis Corporation announced that it expects to receive funding from YIMAI Technology International Company Limited.	15-12-10	CI
Annidis Corporation announced that it has received CAD 0.15 million in funding from YIMAI Technology International Company Limited	15-11-24	CI

Annidis Corporation develops and markets imaging technologies to eye care professionals. The Company has developed a multi-spectral imaging (MSI) system for retinal and choroidal assessment (the RHA). The RHA provides eye-care professionals with a screening tool for early detection and diagnosis of a range of pathologies. The RHA is an ocular pathology management system that integrates MSI with analytic software and management of ocular pathologies, such as glaucoma, age-related macular degeneration and diabetic retinopathy. Its RHA collects and combines multi-spectral information. The RHA is a non-invasive instrument that uses MSI to take pictures of the retinal layers of eye. The images are then processed using the RHA Report software to reveal various layers in the back of the eye. The Company is also engaged in developing RHA Platinum, which is under development with beta units in clinical testing that allows doctors to visualize choroidal and retinal vasculature non-invasively.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+9.48%	222B
DANAHER CORPORATION	+13.72%	195B
INTUITIVE SURGICAL, INC.	+23.79%	148B
BOSTON SCIENTIFIC CORPORATION	+33.39%	113B
SIEMENS HEALTHINEERS AG	+4.75%	66.45B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+3.16%	50.03B
AGILENT TECHNOLOGIES, INC.	-4.35%	38.8B
GE HEALTHCARE TECHNOLOGIES INC.	-1.27%	34.85B
RESMED, INC.	+22.61%	30.98B

Other Advanced Medical Equipment & Technology